Missouri Governor Announces Largest Anti-Smoking Investment in State History

Aug.08.2022
Missouri Governor Announces Largest Anti-Smoking Investment in State History
Missouri Governor announces largest anti-smoking investment in state's history, lauded by healthcare system.

The Governor of Missouri has announced the largest single investment in anti-smoking efforts in the state's history, earning praise from the largest healthcare system in central Missouri.


On August 3, 2022, Don Young, who became mute due to smoking, shared his story with Governor Mike Parson and others. The photo was provided by the governor's Flickr page.


MU Health, headquartered in Columbia, has announced that this move will save Missouri $21 million in healthcare costs. Dr. Kevin Everett, Associate Professor of Family and Community Medicine, expressed excitement about the announcement to 939 the Eagle, stating that "this is a great start. We really need this in Missouri where smoking rates are high and young people are using e-cigarette products. It will be very important to develop cessation programs and access for people.


The Center for Disease Control stated that the use of e-cigarettes poses a safety hazard to children, adolescents, and young adults. Governor Parson announced that $2.5 million will be allocated towards a smoking cessation program, with an initial funding of only $50,000.


Meanwhile, a man from Missouri named Don Young has been left mute due to smoking. He claims to have received thousands of letters, and his story has inspired people to quit smoking. Young spoke at a press conference held by the governor of Columbia, and the room fell silent as he used a machine to communicate.


Everett stated that Don Young's story is very persuasive.


According to Dr. Everett, Don Young leads a difficult and inescapable life, but he is a great advocate for raising awareness about the dangers of smoking.


The Governor stated that the smoking cessation program aims to protect minors from the harmful effects of illegal tobacco sales. Governor Parson noted that tobacco is the leading cause of illness and premature death in Missouri, with 11,000 deaths attributed to smoking each year in the state.


Statement:


This article is compiled from third-party information and intended for industry professionals for communication and learning purposes.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness and accuracy of the article's content. The compilation of this article is only intended for industry exchange and research.


Due to limitations in the level of translation, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


2FIRSTS aligns completely with the position and statements of the Chinese government regarding matters concerning domestic issues, as well as those involving Hong Kong, Macau, Taiwan, and foreign relations.


The compiled information is subject to the copyright of the original media and authors. If there are any infringements, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul will begin fining the use of all tobacco products, including liquid e-cigarettes, in no-smoking areas from April 24, when the revised Tobacco Business Act takes effect.
Apr.09 by 2FIRSTS.ai
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Shenzhen tobacco authorities have asked licensed Chinese vape manufacturers to submit STN details for U.S.-bound products, including CTP Portal or STN email screenshots, highlighting a new compliance signal in cross-border oversight.
Apr.02
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai